Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Mangalam Drugs and Organics Ltd, Remsons Industries Ltd, Asian Granito India Ltd and SMS Lifesciences India Ltd are among the other gainers in the BSE’s ‘B’ group today, 11 April 2022.

Sandur Manganese & Iron Ores Ltd leads gainers in ‘B’ group

Goldiam International Ltd, Williamson Magor & Company Ltd, Mangalam Drugs and Organics Ltd and Gala Global Products Ltd are among the other losers in the BSE’s ‘B’ group today, 31 March 2022.

Future Lifestyle Fashions Ltd leads losers in ‘B’ group

In another transaction, Geojit BNP Paribas Financial Services bought and sold 1 lakh shares of Mangalam Drugs And Organics.

NSE-BSE bulk deals: KBC Eco Fund keeps dumping NCC shares

Mangalam Drugs and Organics Ltd, I G Petrochemicals Ltd, Future Enterprises Ltd and Next Mediaworks Ltd are among the other losers in the BSE’s ‘B’ group today, 09 August 2021.

Chamanlal Setia Exports Ltd leads losers in ‘B’ group

The rating upgrade reflects MD&OL’s robust revenue growth, healthy margins and improved credit metrics in FY21.

Ind-Ra upgrades Mangalam Drugs and Organics to ‘IND BBB/Stable’

Expleo Solutions Ltd, The Investment Trust of India Ltd, Rane (Madras) Ltd and Rana Sugars Ltd are among the other losers in the BSE’s ‘B’ group today, 21 May 2021.